Incidental Mutation 'R5624:Fhit'
ID |
441752 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Fhit
|
Ensembl Gene |
ENSMUSG00000060579 |
Gene Name |
fragile histidine triad gene |
Synonyms |
Fra14A2 |
MMRRC Submission |
043163-MU
|
Accession Numbers |
|
Essential gene? |
Possibly essential
(E-score: 0.604)
|
Stock # |
R5624 (G1)
|
Quality Score |
225 |
Status
|
Validated
|
Chromosome |
14 |
Chromosomal Location |
11307738-12919681 bp(+) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
A to G
at 10421534 bp (GRCm38)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Serine to Proline
at position 85
(S85P)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000124017
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000160340]
[ENSMUST00000160956]
[ENSMUST00000161302]
[ENSMUST00000161895]
[ENSMUST00000162278]
[ENSMUST00000162817]
[ENSMUST00000179394]
|
AlphaFold |
O89106 |
Predicted Effect |
probably damaging
Transcript: ENSMUST00000160340
AA Change: S85P
PolyPhen 2
Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
|
SMART Domains |
Protein: ENSMUSP00000124017 Gene: ENSMUSG00000060579 AA Change: S85P
Domain | Start | End | E-Value | Type |
Pfam:DcpS_C
|
60 |
170 |
2e-9 |
PFAM |
Pfam:HIT
|
72 |
168 |
6.8e-28 |
PFAM |
|
Predicted Effect |
probably damaging
Transcript: ENSMUST00000160956
AA Change: S22P
PolyPhen 2
Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|
SMART Domains |
Protein: ENSMUSP00000123820 Gene: ENSMUSG00000060579 AA Change: S22P
Domain | Start | End | E-Value | Type |
Pfam:HIT
|
9 |
57 |
6.5e-11 |
PFAM |
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000161179
|
Predicted Effect |
probably damaging
Transcript: ENSMUST00000161302
AA Change: S22P
PolyPhen 2
Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|
SMART Domains |
Protein: ENSMUSP00000123874 Gene: ENSMUSG00000060579 AA Change: S22P
Domain | Start | End | E-Value | Type |
Pfam:DcpS_C
|
7 |
110 |
8.2e-10 |
PFAM |
Pfam:HIT
|
9 |
105 |
4.9e-28 |
PFAM |
|
Predicted Effect |
probably damaging
Transcript: ENSMUST00000161895
AA Change: S22P
PolyPhen 2
Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
|
SMART Domains |
Protein: ENSMUSP00000124957 Gene: ENSMUSG00000060579 AA Change: S22P
Domain | Start | End | E-Value | Type |
Pfam:DcpS_C
|
6 |
110 |
4.3e-10 |
PFAM |
Pfam:HIT
|
9 |
105 |
2e-28 |
PFAM |
|
Predicted Effect |
probably damaging
Transcript: ENSMUST00000162278
AA Change: S22P
PolyPhen 2
Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|
SMART Domains |
Protein: ENSMUSP00000124073 Gene: ENSMUSG00000060579 AA Change: S22P
Domain | Start | End | E-Value | Type |
Pfam:DcpS_C
|
7 |
110 |
8.2e-10 |
PFAM |
Pfam:HIT
|
9 |
105 |
4.9e-28 |
PFAM |
|
Predicted Effect |
probably damaging
Transcript: ENSMUST00000162817
AA Change: S22P
PolyPhen 2
Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|
SMART Domains |
Protein: ENSMUSP00000124500 Gene: ENSMUSG00000060579 AA Change: S22P
Domain | Start | End | E-Value | Type |
Pfam:DcpS_C
|
5 |
100 |
2.3e-7 |
PFAM |
Pfam:HIT
|
9 |
100 |
1.9e-24 |
PFAM |
|
Predicted Effect |
probably damaging
Transcript: ENSMUST00000179394
AA Change: S22P
PolyPhen 2
Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|
SMART Domains |
Protein: ENSMUSP00000136011 Gene: ENSMUSG00000060579 AA Change: S22P
Domain | Start | End | E-Value | Type |
Pfam:DcpS_C
|
7 |
110 |
8.2e-10 |
PFAM |
Pfam:HIT
|
9 |
105 |
4.9e-28 |
PFAM |
|
Meta Mutation Damage Score |
0.9218 |
Coding Region Coverage |
- 1x: 99.4%
- 3x: 98.7%
- 10x: 97.3%
- 20x: 95.2%
|
Validation Efficiency |
98% (47/48) |
MGI Phenotype |
FUNCTION: This gene encodes a member of the HIT family of proteins that are characterized by the presence of a histidine triad sequence. The encoded protein is a diadenosine triphosphate hydrolase enzyme that cleaves the P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP. This locus is very fragile and has been found to be altered in different types of cancers. Mice lacking the encoded protein display increased susceptibility to spontaneous and induced tumors. Ectopic expression of the encoded protein in such knockout mice inhibits tumor development. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015] PHENOTYPE: Both homozygotes and heterozygotes for a targeted null mutation exhibit a similarly increased incidence of both spontaneous and nitrosomethylbenzalamine-induced tumors. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 45 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
Adad2 |
T |
A |
8: 120,341,844 (GRCm39) |
|
probably null |
Het |
Aoah |
A |
T |
13: 21,179,649 (GRCm39) |
N372I |
probably damaging |
Het |
Ash1l |
T |
A |
3: 88,892,916 (GRCm39) |
D1598E |
probably damaging |
Het |
Bcas2 |
T |
C |
3: 103,080,577 (GRCm39) |
C72R |
probably benign |
Het |
Car9 |
T |
A |
4: 43,509,146 (GRCm39) |
F238Y |
probably benign |
Het |
Ccnd1 |
T |
C |
7: 144,491,749 (GRCm39) |
S97G |
probably benign |
Het |
Cfap52 |
C |
G |
11: 67,818,184 (GRCm39) |
C509S |
possibly damaging |
Het |
Clcn4 |
C |
A |
7: 7,291,943 (GRCm39) |
V623L |
probably benign |
Het |
Dnajc11 |
T |
C |
4: 152,063,967 (GRCm39) |
V483A |
probably benign |
Het |
E2f8 |
G |
T |
7: 48,527,709 (GRCm39) |
D144E |
probably damaging |
Het |
Epb41l1 |
G |
A |
2: 156,375,691 (GRCm39) |
|
probably benign |
Het |
Fam186a |
A |
C |
15: 99,839,628 (GRCm39) |
H2205Q |
possibly damaging |
Het |
Fzd8 |
G |
A |
18: 9,213,268 (GRCm39) |
G117S |
unknown |
Het |
Gsdmc4 |
A |
G |
15: 63,764,503 (GRCm39) |
M379T |
possibly damaging |
Het |
Hemk1 |
T |
C |
9: 107,208,727 (GRCm39) |
R157G |
probably benign |
Het |
Il10 |
A |
G |
1: 130,951,940 (GRCm39) |
M158V |
probably benign |
Het |
Jmjd1c |
G |
A |
10: 67,069,193 (GRCm39) |
M1656I |
probably damaging |
Het |
Kit |
A |
T |
5: 75,770,054 (GRCm39) |
K155N |
probably benign |
Het |
Lmtk3 |
C |
A |
7: 45,436,286 (GRCm39) |
A114E |
probably damaging |
Het |
Lztr1 |
A |
G |
16: 17,329,993 (GRCm39) |
|
probably benign |
Het |
Mras |
A |
G |
9: 99,293,538 (GRCm39) |
F34S |
probably damaging |
Het |
Myo1c |
A |
G |
11: 75,553,461 (GRCm39) |
T516A |
probably damaging |
Het |
Nme8 |
A |
C |
13: 19,862,038 (GRCm39) |
V197G |
possibly damaging |
Het |
Or13p5 |
T |
A |
4: 118,592,568 (GRCm39) |
Y281N |
probably damaging |
Het |
Or8k39 |
T |
C |
2: 86,563,149 (GRCm39) |
D269G |
probably benign |
Het |
Pcdhb9 |
A |
T |
18: 37,534,459 (GRCm39) |
Y151F |
probably benign |
Het |
Pcnx2 |
C |
T |
8: 126,488,262 (GRCm39) |
|
probably null |
Het |
Plekhg4 |
T |
C |
8: 106,107,382 (GRCm39) |
F892S |
probably damaging |
Het |
Prmt3 |
T |
A |
7: 49,430,082 (GRCm39) |
F62I |
probably damaging |
Het |
Ralgapa1 |
T |
C |
12: 55,659,523 (GRCm39) |
Y1999C |
probably damaging |
Het |
Rims2 |
A |
T |
15: 39,208,809 (GRCm39) |
Q204L |
possibly damaging |
Het |
Slc6a16 |
T |
G |
7: 44,910,532 (GRCm39) |
H352Q |
probably benign |
Het |
Snx9 |
T |
A |
17: 5,942,084 (GRCm39) |
C70* |
probably null |
Het |
Srprb |
A |
G |
9: 103,074,800 (GRCm39) |
I114T |
probably damaging |
Het |
Tas2r119 |
A |
T |
15: 32,178,114 (GRCm39) |
I227F |
probably damaging |
Het |
Tasor2 |
A |
G |
13: 3,634,996 (GRCm39) |
S604P |
possibly damaging |
Het |
Tg |
A |
T |
15: 66,709,906 (GRCm39) |
Y163F |
probably benign |
Het |
Tm2d2 |
A |
G |
8: 25,512,784 (GRCm39) |
T211A |
probably damaging |
Het |
Tmem132b |
A |
G |
5: 125,699,710 (GRCm39) |
S83G |
probably benign |
Het |
Trav9-4 |
T |
C |
14: 53,913,886 (GRCm39) |
S47P |
probably benign |
Het |
Vmn2r8 |
T |
A |
5: 108,950,325 (GRCm39) |
H174L |
probably damaging |
Het |
Xrcc1 |
A |
G |
7: 24,259,270 (GRCm39) |
D85G |
possibly damaging |
Het |
Zfp106 |
C |
G |
2: 120,362,438 (GRCm39) |
A34P |
probably damaging |
Het |
Zfp608 |
A |
T |
18: 55,031,344 (GRCm39) |
N865K |
probably damaging |
Het |
Zscan5b |
A |
G |
7: 6,233,518 (GRCm39) |
D114G |
probably benign |
Het |
|
Other mutations in Fhit |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL01411:Fhit
|
APN |
14 |
9,573,483 (GRCm38) |
missense |
probably benign |
0.19 |
IGL01412:Fhit
|
APN |
14 |
9,870,065 (GRCm38) |
missense |
probably damaging |
1.00 |
IGL02831:Fhit
|
APN |
14 |
9,870,080 (GRCm38) |
missense |
probably benign |
0.00 |
IGL03025:Fhit
|
APN |
14 |
10,421,534 (GRCm38) |
missense |
probably damaging |
1.00 |
overtax
|
UTSW |
14 |
10,421,534 (GRCm38) |
missense |
probably damaging |
1.00 |
R0464:Fhit
|
UTSW |
14 |
10,991,567 (GRCm38) |
start gained |
probably benign |
|
R0544:Fhit
|
UTSW |
14 |
9,870,172 (GRCm38) |
missense |
probably damaging |
1.00 |
R3545:Fhit
|
UTSW |
14 |
9,870,095 (GRCm38) |
missense |
probably benign |
0.03 |
R3547:Fhit
|
UTSW |
14 |
9,870,095 (GRCm38) |
missense |
probably benign |
0.03 |
R3548:Fhit
|
UTSW |
14 |
9,870,095 (GRCm38) |
missense |
probably benign |
0.03 |
R4033:Fhit
|
UTSW |
14 |
10,751,671 (GRCm38) |
intron |
probably benign |
|
R4685:Fhit
|
UTSW |
14 |
9,870,091 (GRCm38) |
missense |
probably damaging |
1.00 |
R4968:Fhit
|
UTSW |
14 |
10,421,522 (GRCm38) |
missense |
probably damaging |
1.00 |
R6011:Fhit
|
UTSW |
14 |
9,870,068 (GRCm38) |
missense |
probably benign |
0.16 |
R6061:Fhit
|
UTSW |
14 |
9,573,435 (GRCm38) |
missense |
probably benign |
0.00 |
R6208:Fhit
|
UTSW |
14 |
9,573,435 (GRCm38) |
missense |
probably benign |
0.00 |
R6846:Fhit
|
UTSW |
14 |
9,763,762 (GRCm38) |
missense |
possibly damaging |
0.73 |
R7288:Fhit
|
UTSW |
14 |
9,763,784 (GRCm38) |
missense |
probably damaging |
1.00 |
R7625:Fhit
|
UTSW |
14 |
9,870,177 (GRCm38) |
critical splice acceptor site |
probably null |
|
R8094:Fhit
|
UTSW |
14 |
10,751,666 (GRCm38) |
missense |
unknown |
|
R8482:Fhit
|
UTSW |
14 |
10,751,616 (GRCm38) |
missense |
probably benign |
0.09 |
R8781:Fhit
|
UTSW |
14 |
10,421,503 (GRCm38) |
missense |
probably damaging |
0.99 |
R9246:Fhit
|
UTSW |
14 |
10,421,494 (GRCm38) |
critical splice donor site |
probably null |
|
Z1177:Fhit
|
UTSW |
14 |
9,870,128 (GRCm38) |
missense |
probably benign |
0.00 |
|
Predicted Primers |
PCR Primer
(F):5'- ATGAATAACATCTTACCTGGACACTCC -3'
(R):5'- CTGGAGTTCATCTGAGGGAC -3'
Sequencing Primer
(F):5'- CCAAAGCAGGAGGAAGGGAGATTC -3'
(R):5'- GGGATCCCATTCTATCAAAGAGTC -3'
|
Posted On |
2016-11-08 |